TUBERCULOSIS INFECTION, LATENT
Clinical trials for TUBERCULOSIS INFECTION, LATENT explained in plain language.
Never miss a new study
Get alerted when new TUBERCULOSIS INFECTION, LATENT trials appear
Sign up with your email to follow new studies for TUBERCULOSIS INFECTION, LATENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Shorter TB regimens could simplify treatment
Disease control Not yet recruitingThis study looks at whether shorter, rifapentine-based treatments for tuberculosis and latent TB are safe and effective in real-world settings in Kazakhstan. It will follow 350 adults, including those with HIV, comparing a 4-month regimen to the standard 6-month one for active TB…
Matched conditions: TUBERCULOSIS INFECTION, LATENT
Sponsor: Public Union "Kazakhstan Association of Phthisiopulmonologists" • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
TB drug liver risk under the microscope
Knowledge-focused Not yet recruitingThis study will track 220 adults being treated for tuberculosis (TB) or latent TB with the drug isoniazid. Researchers want to see how often the drug causes liver injury and what factors make it more likely. They will also look at how doctors manage this side effect in real-world…
Matched conditions: TUBERCULOSIS INFECTION, LATENT
Sponsor: ASST Fatebenefratelli Sacco • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
New study aims to catch TB in pregnant women earlier
Knowledge-focused Not yet recruitingThis study will test better ways to screen for tuberculosis (TB) in pregnant and postpartum women in Guinea-Bissau. Researchers will use a symptom checklist, stool tests, and AI-powered chest X-rays to find more TB cases. The goal is to improve health for mothers and babies and g…
Matched conditions: TUBERCULOSIS INFECTION, LATENT
Phase: NA • Sponsor: Aarhus University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC